Morgan Stanley Maintains Underweight on Virtus Inv, Lowers Price Target to $120

Benzinga Newsdesk www.benzinga.com Negative 74.4%

Neg 74.4% Neu 0% Pos 0%

Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $130 to $120.